New Technologies Lead to Better Patient Outcomes

The Modern Urologist
22/10/2019 20 min Temporada 1 Episodio 4
New Technologies Lead to Better Patient Outcomes

Listen "New Technologies Lead to Better Patient Outcomes "

Descargar episodio

Episode Synopsis

In this episode Dr. Cohen sits down with Dr. Jonathan Henderson, CEO of Regional Urology in Shreveport Louisiana to discuss how the Prolaris test changed his treatment decision of multiple patients considering treatment or active surveillance. Dr. Henderson also talks about his reasoning for the early adoption of hereditary cancer screening and shares a compelling story about how genetic testing for BRCA status allowed him to get a compassionate writ for the PARP inhibitor - Lymparza which dramatically changed his patient's quality of life. Send us a text

More episodes of the podcast The Modern Urologist

Closing the Gap: Overcoming Barriers to Genetic Testing in Prostate Cancer Care 08/05/2025
Personalizing Prostate Cancer Treatment with Germline and Somatic Testing 07/03/2025
Understanding Genetic Tests Across the Patient Journey 13/02/2025
Genetic Testing Basics 09/12/2024
The Role of Advanced Practice Providers in Urology Practices 08/08/2024
Optimizing Prostate Cancer Treatment Decisions with the Prolaris® Test 18/07/2024
The Evolution and Future of LUGPA: A Conversation with Dr. Scott Sellinger 05/07/2024
The Role of Genetic Testing in Prostate Cancer Management 22/05/2024
Go Beyond Gleason for Prostate Cancer Treatment Decisions 22/02/2024
The Power of Collaboration: Enhancing Patient Care Through Urologist and Radiation Oncologist Partnerships 30/08/2023
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA